Plus, Innovega has raised more than $16 million in equity funding from 2800 shareholders.
Appreciation to the Innovega team for the heroic accomplishment.
New resources support development for initial launch and expanded markets.
Broad scope of patent activity includes display and camera technology, assistive technology for the hearing impaired and health maintenance with smart contact lenses.
Licensee plans to deliver new assistive technology for the visually impaired.
Company’s first deployment of its eMacula system targets the visually impaired.
As better technology and application development become more sophisticated, these devices are no longer a future fantasy.
Novel artificial intelligence and telemedicine applications complement methods of manufacturing.
Novel systems help eye care practitioners achieve customization for wearers.
Contact lens materials, topographical instruments, and lens designs have come a long way since then.
Three team members were awarded.
Funds will be earmarked to move Innovega's eMacula toward commercial launch.
Approval enables demonstration and understanding of the significant advantages in placing the optics of a wearable display on or in the eye.
It will allow Innovega to accelerate commercialization.
The company also has a financing round underway.
He was the former AllAboutVision.com publisher.
Get the most important news and business ideas for eyecare professionals every weekday from INVISION.